Osteoporosis in pituitary diseases: lessons for the clinic. Issue 2 (March 2015)

• Record Type: Journal Article
• Authors: Bolanowski, Marek; Jawiarczyk-Przybyłowska, Aleksandra; Halupczok-Żyła, Jowita
• Is Part Of: Expert review of endocrinology & metabolism. Volume 10:Issue 2(2015)
• Page Start: 169
• Page End: 176
• Publication Date: 2015-03
• Subjects: Endocrinology -- Periodicals; Metabolism -- Periodicals; 616.4
• DOI: 10.1586/17446651.2015.983473
• Languages: English
• ISSNs: 1744-6651

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p>Osteoporosis is a systemic disease characterized by bone mass and density loss leading to fragility fractures. Osteoporosis due to endocrine disorders is an example of secondary osteoporosis. The harmful effects on bones are common in patients harboring pituitary tumors (acromegaly, prolactinoma, Cushing's disease) and suffering from hypopituitarism. Increased fracture risk and high healthcare costs of fractured patients are their consequences. The coexistence of some of these disorders and hypogonadism results in severe osteoporosis. The influence of the certain diseases, their activity and therapy and accompanying hypogonadism on bone turnover, bone mineral density and fracture incidence is presented.</p> </abstract>